Accent Capital Management »

Akari Therapeutics Plc Sponsored shares owned by Accent Capital Management

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Accent Capital Management from 13F filings

Historical chart of Accent Capital Management investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Accent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Accent Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 10k 1.01
2025-06-30 $12k 10k 1.17
2025-03-31 $12k 10k 1.24
2024-12-31 $12k 10k 1.22

More positions owned by Accent Capital Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Inc A Cl A Com (GOOG)
Vanguard Growth ETF (VUG)
Meta Platforms Inc A Cl A Com (META)
Spdr S&p 500 Etf (SPY)
Amazon (AMZN)
Vanguard S&p 500 Etf idx (VOO)
Costco Wholesale Corporation (COST)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Honeywell International (HON)

View all positions for Accent Capital Management

Top funds holding Akari Therapeutics Plc Sponsored

Cresset Asset Management
Palo Alto Investors
HighTower Advisors
Omnia Family Wealth
HPM Partners
Virtu Financial
Two Sigma Securities
Independent Advisor Alliance
Accent Capital Management
Goss Wealth Management
UBS Group
Truvestments Capital
EverSource Wealth Advisors
Cornerstone Planning Group
Morgan Stanley

View all funds holding Akari Therapeutics Plc Sponsored